Roche and Spark Therapeutics, Inc. announce expected refiling date of Premerger Notification and Report Forms under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc.

Roche and Spark Therapeutics, Inc. ( “Spark”) today announced that Roche and Spark intend to refile on or about 23 May 2019 their respective Premerger Notification and Report Forms under the Hart-Scott-Rodino Act (the “HSR Act”) in connection with Roche’s pending acquisition of Spark pursuant to its previously announced tende r offer to purchase all of the outstanding shares of common stock (the “Shares”) of Spark for USD 114.50 per Share, net to the seller thereof in cash, without interest and subject to any withholding taxes required by applicable law and upon the terms and subject to the conditions set forth in th e Offer to Purchase dated 7 March 2019 (as it may be amended and supplemented from time to time, the “Offer”).
Source: Roche Media News - Category: Pharmaceuticals Source Type: news

Related Links:

ConclusionsCompressed sensing reduced the acquisition time of conventional MR imaging of the ankle by 20% without decreasing diagnostic image quality, SNR and CNR.
Source: European Journal of Radiology - Category: Radiology Source Type: research
Hilary Nickols, MD, PhDFrom time to time, I feature neuropathologists who exhibit talents beyond the strict confines of neuropathology. For example, I recently features the inimitableMark Cohen and his prodigious classical guitar skills. I discovered another neuropathologist/artist during the recent annual meeting of the American Association of Neuropathologists: Hilary Nickols, MD, PhD, of Norton Healthcare in Louisville, Kentucky. Dr. Nickols shared with me her detailed drawing of a craniotomy surgical field which she recently witnessed during a visit to the operating room.The scene in the operating room, including ...
Source: neuropathology blog - Category: Radiology Tags: neuropathologists Source Type: blogs
Conclusion. This kind of procedure should be kept in the therapeutic armament in the current setting of costly targeted systemic treatments of spondyloarthritis. However, definition of a clear position in the treatment strategy needs further well conducted studies.
Source: Joint Bone Spine - Category: Orthopaedics Source Type: research
ConclusionsPamidronate is a safe and efficient method of CRMO therapy, particularly in cases refractory to NSAIDs treatment. Treatment with pamidronate provides both symptomatic relief as well as normalisation of bone morphology.
Source: Joint Bone Spine - Category: Orthopaedics Source Type: research
Publication date: Available online 16 June 2019Source: Joint Bone SpineAuthor(s): Pierre Letellier, Florian Bailly, Marina Assadourian, Antoine Potel, Violaine Foltz, Sophia Ascione, Laetitia Morardet, Myrianne Le Ralle, Bruno Fautrel, Arnaud Dupeyron, Nada Ibrahim-Nasser, Isabelle Griffoul-Espitalier, Bernard Duplan, Johann Beaudreuil, Laure Gossec
Source: Joint Bone Spine - Category: Orthopaedics Source Type: research
Inducing seizures with cortical stimulation accurately identifies the target area for resection and significantly reduces hospital stays, a new study shows.Medscape Medical News
Source: Medscape Pathology Headlines - Category: Pathology Tags: Neurology & Neurosurgery News Source Type: news
Cochlear Limited has received U.S. Food and Drug Administration (FDA) clearance...Read more on AuntMinnie.comRelated Reading: FDA OKs new MRI-conditional cochlear implant
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
Pfizer has agreed to buy Array Biopharma in a $10.64 billion cash deal.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news
As researchers continue to hunt for ways to treat or prevent Alzheimer ’s disease, one study has shown promise in slowing the progression of the disease.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news
The company started with fewer than 20 employees in 2017.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news
More News: Mergers and Aquisitions | Pharmaceuticals | Tax